These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26395136)

  • 1. The advancement of human pluripotent stem cell-derived therapies into the clinic.
    Thies RS; Murry CE
    Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Pluripotent Stem Cell Mechanobiology: Manipulating the Biophysical Microenvironment for Regenerative Medicine and Tissue Engineering Applications.
    Ireland RG; Simmons CA
    Stem Cells; 2015 Nov; 33(11):3187-96. PubMed ID: 26189759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine.
    Wang YC; Lin V; Loring JF; Peterson SE
    Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine.
    Harris DT; Rogers I
    Curr Stem Cell Res Ther; 2007 Dec; 2(4):301-9. PubMed ID: 18220914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
    Ichimura H; Shiba Y
    Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel.
    Lee SJ; Sohn YD; Andukuri A; Kim S; Byun J; Han JW; Park IH; Jun HW; Yoon YS
    Circulation; 2017 Nov; 136(20):1939-1954. PubMed ID: 28972000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.
    Fox IJ; Daley GQ; Goldman SA; Huard J; Kamp TJ; Trucco M
    Science; 2014 Aug; 345(6199):1247391. PubMed ID: 25146295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerative medicine for Parkinson's disease.
    Yasuhara T; Kameda M; Agari T; Date I
    Neurol Med Chir (Tokyo); 2015; 55(2):113-23. PubMed ID: 25746305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
    Stacey G; Andrews P; Asante C; Barbaric I; Barry J; Bisset L; Braybrook J; Buckle R; Chandra A; Coffey P; Crouch S; Driver P; Evans A; Gardner J; Ginty P; Goldring C; Hay DC; Healy L; Hows A; Hutchinson C; Jesson H; Kalber T; Kimber S; Leathers R; Moyle S; Murray T; Neale M; Pan D; Park BK; Rebolledo RE; Rees I; Rivolta MN; Ritchie A; Roos EJ; Saeb-Parsy K; Schröder B; Sebastian S; Thomas A; Thomas RJ; Turner M; Vallier L; Vitillo L; Webster A; Williams D
    Regen Med; 2018 Dec; 13(8):935-944. PubMed ID: 30488776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration.
    Morizur L; Herardot E; Monville C; Ben M'Barek K
    Mol Cell Neurosci; 2020 Sep; 107():103523. PubMed ID: 32634576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
    Ben M'Barek K; Habeler W; Monville C
    Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Human Pluripotent Stem Cell-derived Endothelial Cells and Their Therapeutic Utility.
    Lee SJ; Kim KH; Yoon YS
    Curr Cardiol Rep; 2018 May; 20(6):45. PubMed ID: 29730842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.